Anne Burger is a seasoned biotech executive with over 15 years of financial leadership experience, recently serving as CFO and interim CEO at CatalYm. She co-founded Breath Therapeutics, leading its sale to Zambon for up to €500M. Anne holds a Business Administration degree from Ludwig-Maximilians-University and has managed multiple successful company exits.
She was instrumental in two major biotech acquisitions: the sale of co-founded Breath Therapeutics to Zambon and Rigontecs sale to MSD, with combined potential deal values approaching €1 billion.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Anne has no verified education history
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.